Pharmaceutical & Biotech Patent Strategies is presented by the International Quality & Productivity Center (IQPC).  The conference brings together experts in the IP industry, government officials, in-house counsel from large and small biotech and pharmaceutical companies, and preeminent legal experts to discuss the current patent issues and how they relate specifically to the pharmaceutical and biotech industries.

MGB partner, Brad Lyerla, will be speaking during a session entitled “Overview of Recent, Important Cases and the Future Implications.”  This session will review the key recent developments in patent litigation, including discussions of Illinois Tool Works v. Independent Ink, Federal Trade Commission v. Schering Plough, Laboratory of America v. Metabolite Las, Merck v. Integra, MedImmune v. Genentech and the eBay case.

For more information about the Pharmaceutical & Biotech Patent Strategies conference, visit the IQPC Web site.

Pharmaceutical and Biotech Patent Strategies Conference
The Hub CityView
Philadelphia, PA
September 26-28, 2006